Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC 1,2-Benzisothiazol-3-amine, N-[2-(1-pyrrolidinyl)phenyl]-, 1,1-dioxide | 874590-32-6 | 99.5% | 327.40 | 1 ML
SDP

Supplier:  Medchemexpress LLC HY11154710MM/1ML

Encompass_Preferred

M1001 is a weak hypoxia-inducible factor-2α (HIF-2α) agonist that binds to the HIF-2α PAS-B domain with a Kd of 667 nM. It can be used in chronic kidney disease research, increasing the expression of HIF-2 target genes modestly in 786-O cells and reducing the physical association between HIF-2α and VHL in HEK293T cells.

  • Target: HIF-2α.
  • Kd: 667 nM (HIF-2α).
  • Appearance: Solid, light green to green.
  • Solubility in DMSO: 250 mg/mL (763.59 mM); requires ultrasonic.
  • Solubility in vivo: ≥ 2.33 mg/mL (7.12 mM) in 10% DMSO, 40% PEG300, 5% Tween-80, 45% Saline.
  • Powder storage: -20°C for 3 years, 4°C for 2 years.
  • In-solvent storage: -80°C for 2 years, -20°C for 1 year.
  • Increases expression of HIF-2 target genes in 786-O cells.
  • Reduces the physical association between HIF-2α and VHL in HEK293T cells.

Catalog No. 50-003-47480


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.